GLADSTONE INSTITUTES, MINGLIANG ZHANG
(See “Cell Reprogramming Successes,” The Scientist, May 2, 2016; M. Zhang et al., “Pharmacological reprogramming of fibroblasts into neural stem cells by signalling-directed transcriptional activation,” Cell Stem Cell, 2016.)